Transcription factor E2F controls the reversible γδ T cell growth arrest mediated through WC1

Journal of Immunology

Volumn 161, Issue 4, 1998, Pages 1630-1636

  Kirkham, Paul A ^a,c   Lam, Eric W F ^b   Takamatsu, Haru Hisa ^a   Parkhouse, R Michael E ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c Novartis Horsham Research Center   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 2; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; CONCANAVALIN A; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DNA-BINDING PROTEINS; DOWN-REGULATION; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; FUNGAL PROTEINS; G0 PHASE; G1 PHASE; GROWTH INHIBITORS; MICROTUBULE-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RETINOBLASTOMA PROTEIN; SHEEP; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0032529607     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Haas, W., P. Pereira, and S. Tonegawa. 1993. γδ cells. Annu. Rev. Immunol. 11:637.
2. Ferrick, D. A., M. D. Schrenzel, T. Mulvania, B. Hsieh, W. G. Ferlin, and W. Lepper. 1995. Differential production of IFN-γ and interleukin-4 in response to Th1-stimulating and Th2-stimulating pathogens by γδ T-cells in vivo. Nature 373:255.
3. Boismenu, R., and W. L. Havran. 1997. An innate view of γδ T cells. Curr. Opin. Immunol. 9:57.
4. Chien, Y. H., and R. Jores. 1995. γδ T-cells: T-cells with B-cell like recognition properties. Curr. Biol. 5:1116.
5. 1 cell cycle arrest. Eur. J. Immunol. 27: 105.
6. Kirkham, P. A., H. H. Takamatsu, and R. M. E. Parkhouse. 1997. Growth arrest of γδ T-cells induced by mAb against WC1 correlates with activation of multiple tyrosine phosphatases and dephosphorylation of MAP kinase erk2. Eur. J. Immunol. 27:717.
7. - γδ T lymphocytes. J. Immunol. 152:3476.
8. 1 events and regulation of cell proliferation. Science 246: 603.
9. Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27(Kip1), a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell-cycle arrest. Genes Dev. 8:9.
10. Grana, X., and E. P. Reddy. 1995. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (cdks), growth suppressor genes and cyclin dependent kinase inhibitors (ckis). Oncogene 11:211.
11. Lees, J. A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13:7813.
12. Hijmans, E. M., P. M. Voorhoeve, R. L. Beijersbergen, L. J. Vantveer, and R. Bernards. 1995. E2F5, a new E2F family member that interacts with p130 in vivo. Mol. Cell Biol. 15:3082.
13. Vairo, G., D. M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869.
14. Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle specific association of E2F with the p130 E1 A-binding protein. Genes Dev. 7:2392.
15. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424.
16. Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. H. Lee, J. Massague, G. R. Crabtree, and J. M. Roberts. 1994. Interleukin-2 mediated elimination of the p27(Kip1) cyclin dependent kinase inhibitor prevented by rapamycin. Nature 372:570.
17. Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a Cdk2 inhibitor during interleukin-2 induced proliferation of human T-lymphocytes. Mol. Cell Biol. 14:4889.
18. Agrawal, D., P. Hauser, F. McPherson, F. Dong, A. Garcia, and W. J. Pledger. 1996. Repression of p27(Kip1) synthesis by platelet derived growth factor in BALB/C 3T3 cells. Mol. Cell. Biol. 16:4327.
19. Takamatsu, H., T. Collen, M. S. Denyer, and M. Windsor. 1993. Interaction of sheep peripheral blood γδ T-cell lines with cells of other phenotypes. Vet. Immunol. Immunopathol. 35:59.
20. Rubin, L. A., C. C. Kurman, W. E. Biddison, N. D. Goldman, and D. L. Nelson. 1985. A mAb 7G7/B6, binds to an epitope on the human interleukin-2 (Il-2) receptor that is distinct from that recognized by Il-2 or anti-Tac. Hybridoma 4:91
21. Lam, E. W. F., and R. J. Watson. 1993. An E2F binding site mediates cell cycle regulated repression of mouse b-Myb transcription. EMBO J. 12:2705.
22. Badara, L. R., E. W. F. Lam, T. S. Sorensen, M. Zamanian, R. Girling, and N. B. La Thangue. 1994. DP1 a cell cycle regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4-Orf-6/7 protein. EMBO J. 13:3104.
23. Johnson, D. G. J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S-phase. Nature 365:349.
24. Bonifacino, J. S., C. K. Suzuki, and R. D. Klausner. 1990. A peptide sequence confers retention and rapid degradation in the endoplasmic reticulum. Science 247:79.
25. Zhng, Y., and S. P. Chellappan. 1995. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 10:2085.
26. Ormondroyd, E., S. De-la-Luna, and N. B. La Thangue. 1995. A new member of the DP family DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogen 11:1437.
27. Sherr, C. J. 1996. Cancer cell-cycles. Science 274:1672.
28. Weinberg, R. A. 1995. The retinoblastoma protein and cell-cycle control. Cell 81:323.
29. 1 cell state. Mol. Cell. Biol. 16:6965.
30. Mayol, X. J. Garriga, and X. Grana. 1995. Cell cycle dependent phosphorylation of the retinoblastoma related protein p130. Oncogene 11:801.
31. Johnson, D. G. 1995. Regulation of E2F1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11:1685.
32. Shirodkar, S., M. Ewen, J. A. Decaprio, J. Morgan, D. M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107 cyclin-A complex in a cell cycle regulated manner. Cell 38:157.
33. Dynlacht, B. D., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev. 8:1772.
34. Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161.
35. DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. R. Nevins. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245.
36. Shan, B., A. A. Farmer, and W. H. Lee. 1996. The molecular basis of E2F1/DP1 induced S-phase entry and apoptosis. Cell Growth Differ. 7:689.
37. Polyak, K., M. H. Lee, H. Erdjumentbromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27(Kip1), a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59.
38. Schulze, A., K. Zerfassthome, J. Berges, S. Middendorp, P. Jansendurr, and B. Henglein. 1996. Anchorage-dependent transcription of the cyclin A gene. Mol. Cell. Biol. 16:4632.
39. Perkins, G. R., J. Marvel, and M. K. L. Collins. 1993. Interleukin-2 activates extracellular signal regulated protein kinase-2. J. Exp. Med. 178:1429.
40. Kawada, M., S. Yamagoe, Y. Murakami, K. Suzuki, S. Mizuno, and Y. Uehara. 1997. Induction of p27(Kip1) degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15:629.